We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




U.S. Expands BSE Testing Program in Cows

By HospiMedica staff writers
Posted on 30 Mar 2004
Following an identified U.S. More...
case of mad cow disease, or bovine spongiform encephalopathy (BSE), the U.S. Department of Agriculture (USDA, Washington, DC, USA) has announced an expansion in its program of testing cows.

The USDA plans to test approximately 400,000 cows over the next 12-18 months and has licensed the rapid BSE test of Bio-Rad Laboratories, Inc. (Hercules, CA, USA; www.bio-rad.com). Called TeSeE, the test is for use by the U.S. National Veterinary Service Laboratories (Ames, IA, USA), which will do the actual testing.

"We are pleased that our test has met the stringent requirements of the USDA qualification process,” remarked Brad Crutchfield, vice president of Life Science at Bio-Rad. "Bio-Rad has extensive experience working with more than 500 labs in 25 countries around the world that screen for BSE.”

Bio-Rad's test detects the presence of the resistant form of prion protein, or PrPres, linked to BSE and can identify these prions at extremely low levels. The capability to detect very low levels of prions helps ensure that BSE-infected animals do not go undetected. The BSE test is also the easiest testing method to adapt to mass screening programs, according to the company. The test runs on an automated robotics platform and can produce results in just four hours, or can process up to 1,000 samples in eight hours.

"The test's speed, ease-of-use, high degree of sensitivity and accuracy have placed it in the highest scientific regard and will aid in the USDA's efforts to conduct a reliable and highly effective surveillance program,” added Mr. Crutchfield.

Bio-Rad is the leading provider of tests for detecting diseases in the field of transmissible spongiform encephalopathies (TSEs), having provided more than 22 million BSE tests to laboratories throughout Europe and Japan. The company also supplies tests for other TSEs, including chronic wasting disease (CWD), found in deer and elk.

"In Colorado, we have tested nearly 47,000 deer and elk in the last 18 months using Bio-Rad's CWD test,” said Dr. Barbara Powers, director of Colorado State University's Veterinary Diagnostic Laboratory, who worked closely with the Colorado Division of Wildlife on the 2002 field validation studies of Bio-Rad's CWD test. "The test has proven to be extremely accurate, fast, very easy to perform, and it is also efficient and cost effective,” Dr. Powers added.




Related Links:
Bio-Rad
USDA

Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Syringe Pump
SP50 Series
Medical Adhesive
MED 5570U
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.